护理学报 ›› 2023, Vol. 30 ›› Issue (20): 10-15.doi: 10.16460/j.issn1008-9969.2023.20.010
肌少症筛查量表在老年患者中的应用进展
林丽君1, 金瑛2, 朱可嘉1, 徐好1, 汪晨1
- 1.浙江中医药大学 护理学院,浙江 杭州 310000;
2.浙江中医药大学附属第二医院 护理部,浙江 杭州 310005
摘要： 目的 对肌少症筛查量表在老年患者中应用现状进行综述,为国内临床选择适合的肌少症筛查工具提供参考。方法 检索国内外数据库相关文献,从肌少症的概念、常用筛查量表、不同系统疾病的应用现状、不同机构的应用现状等方面进行综述。结果 汇总肌少症常用筛查量表共8个,分别是小腿围、简易5项评分问卷、简易5项评分问卷结合小腿围、简易5项评分问卷结合年龄和体质量指数、5条目迷你肌少症风险评估问卷、7条目迷你肌少症风险评估问卷、指环试验和Ishii评分,分别介绍了各个量表的条目、分类界值、开发人群、开发国家等特点。以上量表均已在我国应用,其中简易5项评分问卷应用最为广泛,简易5项评分问卷结合小腿围和5条目迷你肌少症风险评估问卷筛查准确性更佳,部分改良版量表也显示出较好的可靠性。结论 目前肌少症筛查量表各有优缺点,建议在医疗机构的临床应用中,优先选择筛查准确性稳定的量表,避免漏筛;在社区和养老机构的临床应用中,优先选择简便、快速、有效的量表,节省医疗资源。
中图分类号:
- R473.59
| [1] Gao K, Ma WZ, Huck S, et al.Association between sarcopenia and depressive symptoms in Chinese older adults: evidence from the China Health and Retirement Longitudinal Study[J]. Front Med (Lausanne), 2021,8:755705. DOI: 10.3389/fmed.2021.755705. [2] 徐俊骅, 李莉, 吴霜, 等. 肌少症与认知功能障碍相关性的系统评价[J]. 中国循证医学杂志, 2023,23(3):341-345.DOI: 10.7507/1672-2531.202208067. [3] Kawakami R, Murakami H, Sanada K, et al.Calf circumference as a surrogate marker of muscle mass for diagnosing sarcopenia in Japanese men and women[J]. Geriatr Gerontol Int, 2015,15(8):969-976.DOI: 10.1111/ggi.12377. [4] Malmstrom TK, Morley JE.SARC-F: a simple questionnaire to rapidly diagnose sarcopenia[J]. J Am Med Dir Assoc, 2013,14(8):531-532.DOI: 10.1016/j.jamda.2013.05.018. [5] Barbosa-Silva TG, Menezes AM, Bielemann RM, et al.Enhancing SARC-F: improving sarcopenia screening in the clinical practice[J]. J Am Med Dir Assoc,2016,17(12):1136-1141.DOI: 10.1016/j.jamda.2016.08.004. [6] Kurita N, Wakita T, Kamitani T, et al.SARC-F validation and SARC-F+EBM derivation in musculoskeletal disease: the SPSS-OK study[J]. J Nutr Health Aging, 2019,23(8):732-738. DOI: 10.1007/s12603-019-1222-x. [7] Rossi AP, Micciolo R, Rubele S, et al.Assessing the risk of sarcopenia in the elderly: the mini sarcopenia risk assessment (MSRA)questionnaire[J]. J Nutr Health Aging, 2017,21(6):743-749. DOI:10.1007/s12603-017-0921-4. [8] Watanabe D, Yoshida T, Nakagata T, et al.Factors associated with sarcopenia screened by finger-circle test among middle-aged and older adults: a population-based multisite cross-sectional survey in Japan[J]. BMC Public Health, 2021,21(1):798.DOI: 10.1186/s12889-021-10844-3. [9] Ishii S, Tanaka T, Shibasaki K, et al. Development of a simple screening test for sarcopenia in older adults[J]. Geriatr Gerontol Int,2014,14 Suppl 1:93-101.DOI:10.1111/ggi.12197. [10] 马铮, 杨新春, 吴兴利. 老年人肌少症与心血管疾病共病研究进展[J]. 中华老年多器官疾病杂志,2020,19(9):709-712.DOI: 10.11915/j.issn.1671-5403.2020.09.165. [11] Barbalho SM, Flato U, Tofano RJ, et al.Physical exercise and myokines: relationships with sarcopenia and cardiovascular complications[J]. Int J Mol Sci, 2020,21(10):3607.DOI: 10.3390/ijms21103607. [12] Zuo X, Li X, Tang K, et al.Sarcopenia and cardiovascular diseases: a systematic review and meta-analysis[J]. J Cachexia Sarcopenia Muscle, 2023,14(3):1183-1198.DOI: 10.1002/jcsm.13221. [13] Noda T, Kamiya K, Hamazaki N, et al.SARC-F predicts poor motor function, quality of life, and prognosis in older patients with cardiovascular disease and cognitive impairment[J]. Exp Gerontol, 2023,171:112021.DOI: 10.1016/j.exger.2022.112021. [14] 董小久. 老年冠心病患者合并肌少症的相关性研究[D]. 太原:山西医科大学, 2021. [15] Zhao W, Lu M, Wang X, et al.The role of sarcopenia questionnaires in hospitalized patients with chronic heart failure[J]. Aging Clin Exp Res, 2021, 33(2):339-344.DOI:10.1007/s40520-020-01561-9. [16] 南亚昀, 彭琳琳, 高叙凡, 等. 慢性阻塞性肺疾病合并肌少症[J]. 中国实用内科杂志, 2022,42(8):626-630.DOI: 10.19538/j.nk2022080104. [17] 谢灿辉, 黄丹, 黎东明. 慢性阻塞性肺疾病合并肌少症的研究进展[J]. 中国医学创新, 2022,19(26):179-183.DOI: 10.3969/j.issn.1674-4985.2022.26.043. [18] Sepulveda-Loyola W, Osadnik C, Phu S, et al.Diagnosis, prevalence, and clinical impact of sarcopenia in COPD: a systematic review and Meta-analysis[J].J Cachexia Sarcopenia Muscle, 2020,11(5):1164-1176.DOI: 10.1002/jcsm.12600. [19] Espindola DAB, Teixeira PP, Valduga K, et al.Prevalence, associated factors, and prognostic value of sarcopenia in patients with acute exacerbated chronic obstructive pulmonary disease: a cohort study[J].Clin Nutr ESPEN, 2021,42:188-194.DOI: 10.1016/j.clnesp.2021.01.042. [20] Hanada M, Sakamoto N, Ishimoto H, et al.A comparative study of the sarcopenia screening in older patients with interstitial lung disease[J]. BMC Pulm Med, 2022,22(1):45.DOI: 10.1186/s12890-022-01840-3. [21] Dasarathy S, Merli M.Sarcopenia from mechanism to diagnosis and treatment in liver disease[J]. J Hepatol, 2016,65(6):1232-1244.DOI: 10.1016/j.jhep.2016.07.040. [22] 刘雪纯,荆雪.肝硬化合并肌少症发病机制的研究进展[J]. 胃肠病学和肝病学杂志, 2023, 32(1):106-109. DOI:10.3969/j.issn.1006-5709.2023.01.022. [23] Hanai T, Shiraki M, Ohnishi S, et al.Rapid skeletal muscle wasting predicts worse survival in patients with liver cirrhosis[J]. Hepatol Res,2016,46(8):743-751.DOI:10.1111/hepr.12616. [24] Kikuchi N, Uojima H, Hidaka H, et al.Prospective study for an independent predictor of prognosis in liver cirrhosis based on the new sarcopenia criteria produced by the Japan Society of Hepatology[J]. Hepatol Res, 2021,51(9):968-978. DOI: 10.1111/hepr.13698. [25] 孙慧慧, 孙菊, 程莉洁, 等. 肝移植受者术前预康复的研究进展[J]. 护理学报, 2022,29(15):39-44.DOI: 10.16460/j.issn.1008-9969.2022.15.039. [26] Hiraoka A, Nagamatsu K, Izumoto H, et al.SARC-F combined with a simple tool for assessment of muscle abnormalities in outpatients with chronic liver disease[J]. Hepatol Res, 2020,50(4):502-511.DOI: 10.1111/hepr.13469. [27] Ichikawa T, Miyaaki H, Miuma S, et al.Comparison of calculated body muscle mass and SARC-F as methods of screening for sarcopenia in patients with chronic liver disease[J]. Biomed Rep, 2021,14(4):34. DOI:10.3892/br.2021.1410. [28] 马勇鹏, 李鹏杰, 王驰, 等. 肌少症与糖尿病心血管病变关系研究的进展[J]. 心血管康复医学杂志, 2022,31(5):649-653.DOI: 10.3969/j.issn.1008-0074.2022.05.27. [29] 张莎, 祝德秋, 侯幸赟. 降糖药物与2型糖尿病患者肌少症相关性的研究进展[J].山西医药杂志, 2023,52(8):603-609.DOI:10.3969/j.issn.0253-9926.2023.08.010. [30] Liccini A, Malmstrom TK.Frailty and sarcopenia as predictors of adverse health outcomes in persons with diabetes mellitus[J]. J Am Med Dir Assoc, 2016,17(9):846-851.DOI: 10.1016/j.jamda.2016.07.007. [31] Ida S, Nakai M,Ito S, et al.Association between sarcopenia and mild cognitive impairment using the Japanese version of the SARC-F in elderly patients with diabetes[J]. J Am Med Dir Assoc, 2017,18(9):809.DOI: 10.1016/j.jamda.2017.06.012. [32] Ida S, Murata K, Nakai M, et al.Relationship between sarcopenia and depression in older patients with diabetes: an investigation using the Japanese version of SARC-F[J]. Geriatr Gerontol Int, 2018,18(9):1318-1322.DOI: 10.1111/ggi.13461. [33] Xu Z, Zhang P, Chen Y, et al.Comparing SARC-CalF with SARC-F for screening sarcopenia in adults with type 2 diabetes mellitus[J]. Front Nutr, 2022,9:803924.DOI: 10.3389/fnut.2022.803924. [34] 何清华, 王秀芝, 杨彩哲, 等. 上臂围用于评估老年2型糖尿病患者低肌肉含量的临床价值[J].中华糖尿病杂志, 2023(1):14-19. DOI:10.3760/cma.j.cn115791-20220530-00244. [35] Esteves CL, Ohara DG, Matos AP, et al.Anthropometric indicators as a discriminator of sarcopenia in community-dwelling older adults of the Amazon region: a cross-sectional study[J]. BMC Geriatr, 2020,20(1):518.DOI: 10.1186/s12877-020-01923-y. [36] 黄宏兴, 史晓林, 李盛华, 等. 肌少-骨质疏松症专家共识[J]. 中国骨质疏松杂志, 2022,28(11):1561-1570.DOI: 10.3969/j.issn.1006-7108.2022.11.001. [37] 林贤灿, 吴建军, 杨志杰, 等. 肌少—骨质疏松症研究现状及展望[J]. 中国骨质疏松杂志, 2023,29(5):676-681.DOI: 10.3969/j.issn.1006-7108.2023.05.011. [38] 韩婷, 钱绪芬, 王庆芳, 等. 基于Logistic回归和决策树模型的老年住院患者肌少症风险的影响因素分析[J]. 护理学报, 2022,29(12):56-62.DOI: 10.16460/j.issn.1008-9969.2022.12.056. [39] Genest F, Rak D, Batz E, et al.Sarcopenia and malnutrition screening in female osteoporosis patients-a cross-sectional study[J]. J Clin Med, 2021,10(11):2344. DOI:10.3390/jcm10112344. [40] 徐腊梅, 高淑清. 肌肉减少症与肿瘤发生关系的研究进展[J]. 肿瘤代谢与营养电子杂志, 2022,9(6):701-706.DOI: 10.16689/j.cnki.cn11-9349/r.2022.06.004. [41] 李向阳, 李凡, 张树泽, 等. 肿瘤相关性肌少症研究进展[J]. 解放军医学杂志, 2022,47(7):739-744.DOI:10.11855/j.issn.0577-7402.2022.07.0739. [42] 张莹, 朱永健. 360例胃肠道肿瘤患者术前合并肌肉减少症的现状及影响因素分析[J]. 护理学报, 2023,30(8):17-22.DOI: 10.16460/j.issn.1008-9969.2023.08.017. [43] Kazemi-Bajestani SM, Mazurak VC, Baracos V.Computed tomography-defined muscle and fat wasting are associated with cancer clinical outcomes[J]. Semin Cell Dev Biol, 2016,54:2-10DOI: 10.1016/j.semcdb.2015.09.001. [44] Fu X, Tian Z, Thapa S, et al.Comparing SARC-F with SARC-CalF for screening sarcopenia in advanced cancer patients[J]. Clin Nutr, 2020,39(11):3337-3345. DOI: 10.1016/j.clnu.2020.02.020. [45] Ribeiro LS, Souza B, de Lima JB, et al. Cross-cultural adaptation of the brazilian portuguese-translated version of the Mini Sarcopenia Risk Assessment (MSRA) Questionnaire in cancer patients[J].Clin Pract, 2021,11(2):395-403. DOI: 10.3390/clinpract11020054. [46] Chen Z, Li WY, Ho M, et al.The prevalence of sarcopenia in chinese older adults: Meta-analysis and Meta-regression[J]. Nutrients, 2021,13(5):1441.DOI: 10.3390/nu13051441. [47] 钟静,沈鸣霞,汪铭涵,等. 浙江省杭州市医护人员肌少症知信行现状调查分析[J]. 上海医药, 2022,43(16):18-22. [48] 薛晓燕, 秦泰然, 武琪, 等. 三种肌少症评估工具筛查社区老年人肌少症效果比较[J]. 护理学杂志, 2021,36(20):10-14.DOI: 10.3870/j.issn.1001-4152.2021.20.010. [49] 黄倩, 徐慧萍, 张艳, 等. 社区慢性病共病老年患者肌少症筛查工具的比较研究[J]. 中华护理杂志, 2022,57(24):3017-3021.DOI:10.3761/j.issn.0254-1769.2022.24.011. [50] 李敏, 宋瑰琦, 任海燕, 等. Ishii评分在社区老年人肌少症筛查中的应用[J]. 中国护理管理, 2018,18(8):1034-1038.DOI:10.3969/j.issn.1672-1756.2018.08.007. [51] Woo J, Yu R, Leung J.A 3-Item SARC-F[J]. J Am Med Dir Assoc, 2018,19(3):223-228.DOI: 10.1016/j.jamda.2017.09.006. [52] Li R, Hu X, Tan L, et al.Screening for sarcopenia with a self-reported cartoon questionnaire: combining SARC-F with finger-ring test[J]. J Nutr Health Aging, 2020,24(10):1100-1106.DOI: 10.1007/s12603-020-1445-x. [53] Yao R, Yao L, Yuan C, et al.Accuracy of calf circumference measurement, SARC-F questionnaire, and Ishii’s score for screening stroke-related sarcopenia[J]. Front Neurol, 2022,13:880907. DOI: 10.3389/fneur.2022.880907. [54] Hax V, Do ESR, Dos SL, et al.Practical screening tools for sarcopenia in patients with systemic sclerosis[J].PLoS One,2021,16(1):e245683.DOI:10.1371/journal.pone.0245683. [55] Nishikawa H, Yoh K, Enomoto H, et al.Clinical impact of the finger-circle test in patients with liver diseases[J]. Hepatol Res,2021,51(5):603-613.DOI:10.1111/hepr.13639. [56] Rossi AP, Caliari C, Urbani S, et al.Sarcopenia risk evaluation in a sample of hospitalized elderly men and women: combined use of the mini sarcopenia risk assessment (MSRA) and the SARC-F[J]. Nutrients, 2021,13(2):635.DOI: 10.3390/nu13020635. [57] 廖书雯. 重庆市养老院人群肌肉减少症患病率调查及相关危险因素研究[D]. 重庆:重庆医科大学, 2018. [58] Chen CY, Tseng WC, Yang YH, et al.Calf circumference as an optimal choice of four screening tools for sarcopenia among ethnic Chinese older adults in assisted living[J]. Clin Interv Aging,2020,15:2415-2422.DOI:10.2147/CIA.S287207. |
| [1] | 周祎敏, 姚宇哲, 叶旭春. 社区老年人对照护机器人感知与期望的Meta整合[J]. 护理学报, 2023, 30(9): 43-48. |
| [2] | 孙小卫, 王燕, 闵春燕, 段菲, 肖江琴. 322例老年COPD患者生活空间现状及影响因素分析[J]. 护理学报, 2023, 30(8): 1-6. |
| [3] | 任影, 于卫华, 张利, 郑俊俊, 邓曼, 杨侠, 张雨溪. 社区老年人生活空间水平现状及影响因素分析[J]. 护理学报, 2023, 30(7): 11-15. |
| [4] | 贺丽春. 失智症老年人蒙台梭利型非药物干预研究进展[J]. 护理学报, 2023, 30(5): 38-41. |
| [5] | 李淼, 沈军, 赵庆华, 陈秋, 廖晓艳, 任柳, 张虹. 对社区老年人基于Z-R需求模型智慧养老服务的效果观察[J]. 护理学报, 2023, 30(20): 75-78. |
| [6] | 李娜, 黄懿炘, 刘美兰, 邓银辉, 邹小芳. 老年人健康促进行为量表的汉化及信效度评价[J]. 护理学报, 2023, 30(17): 5-10. |
| [7] | 王若仙, 何斌, 王玉环, 刘柯汝, 唐雪婷, 赵淑华, 魏杉杉. 社区老年人骨质疏松性骨折风险感知偏差现况及影响因素分析[J]. 护理学报, 2023, 30(15): 1-5. |
| [8] | 王芸芸, 熊吴燕, 王秀红, 王先美. 本科护生“老年护理学”社会实践教学学习体验的现象学研究[J]. 护理学报, 2023, 30(14): 28-31. |
| [9] | 崔芸荟, 王宇, 马平萍, 郭鑫鑫, 杨巧芳. 心血管疾病老年患者社会隔离影响因素及管理策略进展[J]. 护理学报, 2023, 30(14): 42-45. |
| [10] | 曾迎春, 曾玲晖. 健康老龄化视域下智慧康养元宇宙的应用现状、挑战与对策[J]. 护理学报, 2023, 30(14): 70-72. |
| [11] | 陈羽保, 周璐, 廖艳芳, 郭飏, 付雪连, 肖敏. 高职涉老专业学生数字反哺机构养老人群的研究[J]. 护理学报, 2023, 30(11): 27-30. |
| [12] | 夏青, 肖凤凤, 彭心雨, 游雅菲, 周婷格, 王冬华. 自主性感知在农村老年人死亡焦虑和自我养老能力间的中介作用[J]. 护理学报, 2022, 29(9): 52-57. |
| [13] | 康艳楠, 魏文彤, 王瑞瑞, 张春梅, 刘彦慧. 基于马斯洛需求层次理论农村留守老年人社会支持需求评估体系的构建[J]. 护理学报, 2022, 29(8): 1-6. |
| [14] | 沈影, 王梅, 罗迎霞, 谢雅瑞, 毛惠娜. 基于能力-机会-动机-行为模型老年肺癌衰弱患者健康促进方案的构建[J]. 护理学报, 2022, 29(6): 65-70. |
| [15] | 胡惠菊, 郭雪琪, 唐启群, 成杰, 李慧源, 李田田. 衰老认知在养老机构老年人领悟社会支持与内在力量间的中介效应[J]. 护理学报, 2022, 29(3): 57-61. |
|